title: Intralesional Methotrexate for Treatment of Invasive Squamous Cell Carcinomas in a Patient Taking Vemurafenib for Treatment of Metastatic Melanoma.
authors.affiliation: University of Iowa, Iowa City, IA.
authors.forename: Molly S
authors.initials: MS
authors.lastname: Moye
authors.affiliation: University of Iowa, Iowa City, IA.
authors.forename: Ashlynne H
authors.initials: AH
authors.lastname: Clark
authors.affiliation: University of Iowa, Iowa City, IA.
authors.forename: Allison A
authors.initials: AA
authors.lastname: Legler
authors.affiliation: University of Iowa, Iowa City, IA.
authors.forename: Mohammed M
authors.initials: MM
authors.lastname: Milhem
authors.affiliation: University of Iowa, Iowa City, IA marta-vanbeek@uiowa.edu.
authors.forename: Marta J
authors.initials: MJ
authors.lastname: Van Beek
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D013449:Sulfonamides / Q000008:administration & dosage; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D008727:Methotrexate